Regeneron Pharmaceuticals (REGN)
CapEx to Revenue
5.60%
Quarterly · Period ending:
REGN CapEx to Revenue
Latest reported5.60%period ending
Latest reported5.60%period ending
REGN Quarterly CapEx/Revenue (0.00% → 5.60%)
Latest values, visible window
High-resolution chart · PNG
REGN capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 38.2938% | |
| 18.0848% | |
| 6.0002% | |
| 6.9838% | |
| 17.4184% | |
| 16.8699% | |
| 6.7227% | |
| 10.6195% | |
| 45.7627% | |
| 18.1818% | |
| 8.1081% | |
| 12.037% | |
| 1.4815% | |
| 13.8462% | |
| 5.2632% | |
| 4.4944% | |
| 1.5152% | |
| 19.3548% | |
| 9.2308% | |
| 8.0645% | |
| 43.5484% | |
| 92.3077% | |
| 46.5517% | |
| 6.4516% | |
| 1.3158% | |
| 1.4493% | |
| 6.4935% | |
| 7.8652% | |
| 33.3333% | |
| 183.3333% | |
| 279.3103% | |
| 33.3333% | |
| 53.8462% | |
| 9.5238% | |
| 2,169.5652% | |
| 2,116.6667% | |
| 21.875% | |
| 14.2857% | |
| 40% | |
| 5.2632% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |